Health Condition 1: N920- Excessive and frequent menstruation with regular cycle
Conditions
Interventions
Intervention1: Tranexemic acid: 500mg tds orally from 3rd day
of cycle for 15 days in tablet
form for 3 cycles
Control Intervention1: Extract of Unani Polyherbal Formulation- Anjbar(� Poligonum bis
Sponsors
Ayurvedic and Unani Tibbia College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: Women in the age group of 20 to 40 years. Women who have more than 80 ml blood loss during their menstrual cycle. Patients willing to sign the informed consent follow the protocol and participate in clinical trial voluntarily. The patient with PCOD, Ovarian cyst.
Exclusion criteria
Exclusion criteria: The patient with uterine fibroid. The patient was unwilling to sign the consent form. The patient has a history of AIDS, syphilis, and gonorrhoea. History of cardiovascular, renal, or liver disease History of diabetes (Type 1 or Type 2) Patients with systemic disease and malignancy Individuals of alcohol and other substance abuse. Pregnant and lactating women. Females who become pregnant during the study become excluded. Individuals who have a history of drug therapy used three months previous to enrolment in the study. Individuals with untreated thyroid disease/bleeding disorders. Patient having IUCD.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ââ?¬Â¢ To assess the safety of Unani formulations in the management of Kasrat-etams(menorrhagia). ââ?¬Â¢ To assess the efficacy of Unani formulations in the management of Kasrat-e tams(menorrhagia)Timepoint: 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the improvement of quality of life in test group patients Timepoint: 3 months | — |
Countries
India
Contacts
Public ContactDr Varda Naaz
Ayurvedic and Unani Tibbia College and Hospital
Outcome results
None listed